ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 315 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $287,509 | -24.6% | 10,700 | 0.0% | 0.03% | -31.6% |
| Q2 2023 | $381,562 | +15.6% | 10,700 | -17.7% | 0.04% | +22.6% |
| Q1 2023 | $330,200 | -37.4% | 13,000 | 0.0% | 0.03% | -36.7% |
| Q4 2022 | $527,280 | +22.6% | 13,000 | 0.0% | 0.05% | +22.5% |
| Q3 2022 | $430,000 | -6.1% | 13,000 | 0.0% | 0.04% | +11.1% |
| Q2 2022 | $458,000 | -23.4% | 13,000 | 0.0% | 0.04% | -18.2% |
| Q1 2022 | $598,000 | -30.6% | 13,000 | 0.0% | 0.04% | -17.0% |
| Q4 2021 | $862,000 | +6.2% | 13,000 | 0.0% | 0.05% | -10.2% |
| Q3 2021 | $812,000 | -24.6% | 13,000 | 0.0% | 0.06% | -33.0% |
| Q2 2021 | $1,077,000 | +24.9% | 13,000 | 0.0% | 0.09% | +10.0% |
| Q1 2021 | $862,000 | -13.5% | 13,000 | 0.0% | 0.08% | -27.9% |
| Q4 2020 | $997,000 | – | 13,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |